• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HMGB1 作为恶性间皮瘤的潜在生物标志物和治疗靶点。

HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma.

机构信息

Institute of Occupational Diseases, Zhejiang Academy of Medical Sciences, Hangzhou 310013, China.

Department of General Surgery, Sir Run Run Shaw Hospital Affiliated to Medical College of Zhejiang University, Hangzhou 310016, China.

出版信息

Dis Markers. 2019 Feb 12;2019:4183157. doi: 10.1155/2019/4183157. eCollection 2019.

DOI:10.1155/2019/4183157
PMID:30891101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6390248/
Abstract

Malignant mesothelioma (MM) is a rare, aggressive, and highly lethal cancer that is substantially induced by exposure to asbestos fibers. High-mobility group box 1 (HMGB1) is an intriguing proinflammatory molecule involved in MM. In this review, we describe the possible crucial roles of HMGB1 in carcinogenic mechanisms based on and experimental evidence and outline the clinical findings of epidemiological investigations regarding the possible roles of HMGB1 as a biomarker for MM. We conclude that novel strategies targeting HMGB1 may suppress MM cells and interfere with asbestos-induced inflammation.

摘要

恶性间皮瘤(MM)是一种罕见的、侵袭性的、高度致命的癌症,主要由暴露于石棉纤维引起。高迁移率族蛋白 B1(HMGB1)是一种引人关注的促炎分子,与 MM 有关。在这篇综述中,我们根据 和 实验证据描述了 HMGB1 在致癌机制中可能的关键作用,并概述了关于 HMGB1 作为 MM 生物标志物的可能作用的流行病学研究的临床发现。我们的结论是,针对 HMGB1 的新策略可能抑制 MM 细胞并干扰石棉诱导的炎症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ec/6390248/b66aa189fe57/DM2019-4183157.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ec/6390248/b66aa189fe57/DM2019-4183157.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ec/6390248/b66aa189fe57/DM2019-4183157.001.jpg

相似文献

1
HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma.HMGB1 作为恶性间皮瘤的潜在生物标志物和治疗靶点。
Dis Markers. 2019 Feb 12;2019:4183157. doi: 10.1155/2019/4183157. eCollection 2019.
2
Overexpression of fibulin-3 in tumor tissue predicts poor survival of malignant mesothelioma patients from hand-spinning asbestos exposed area in eastern China.纤维连接蛋白-3 在肿瘤组织中的过表达预示着来自中国东部手纺石棉暴露地区的恶性间皮瘤患者的生存不良。
Sci Rep. 2020 Nov 23;10(1):20373. doi: 10.1038/s41598-020-77412-4.
3
HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.丙酮酸乙酯靶向HMGB1可抑制人恶性间皮瘤的恶性表型。
Oncotarget. 2017 Apr 4;8(14):22649-22661. doi: 10.18632/oncotarget.15152.
4
Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression.阿司匹林通过抑制高迁移率族蛋白B1(HMGB1)介导的肿瘤进展来延缓间皮瘤的生长。
Cell Death Dis. 2015 Jun 11;6(6):e1786. doi: 10.1038/cddis.2015.153.
5
The role of high-mobility group protein box 1 in lung cancer.高迁移率族蛋白 box1 在肺癌中的作用。
J Cell Biochem. 2018 Aug;119(8):6354-6365. doi: 10.1002/jcb.26837. Epub 2018 Apr 17.
6
Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases.血清高迁移率族蛋白B1作为石棉相关疾病患者的潜在生物标志物。
Dis Markers. 2017;2017:5756102. doi: 10.1155/2017/5756102. Epub 2017 Mar 1.
7
High mobility group box 1 mediates inflammatory responses in malignant peritoneal mesothelioma.高迁移率族蛋白 B1 介导恶性腹膜间皮瘤的炎症反应。
Int Immunopharmacol. 2024 May 30;133:112039. doi: 10.1016/j.intimp.2024.112039. Epub 2024 Apr 12.
8
Biological agents involved in malignant mesothelioma: relevance as biomarkers or therapeutic targets.恶性间皮瘤相关的生物制剂:作为生物标志物或治疗靶点的相关性。
Curr Cancer Drug Targets. 2010 Feb;10(1):19-26. doi: 10.2174/156800910790980232.
9
Expression analysis of HMGB1 in histological samples of malignant pleural mesothelioma.HMGB1 在恶性胸膜间皮瘤组织学样本中的表达分析。
Histopathology. 2018 May;72(6):1039-1050. doi: 10.1111/his.13470. Epub 2018 Feb 26.
10
Differential expression of extracellular matrix constituents and cell adhesion molecules between malignant pleural mesothelioma and mesothelial hyperplasia.恶性胸膜间皮瘤与间皮细胞增生中细胞外基质成分和细胞黏附分子的差异表达。
J Thorac Oncol. 2013 Nov;8(11):1389-95. doi: 10.1097/JTO.0b013e3182a59f45.

引用本文的文献

1
HMGB1 as a Key Mediator in Malignant Mesothelioma and a Potential Target for Asbestos-Related Cancer Therapy.高迁移率族蛋白B1作为恶性间皮瘤的关键介质及石棉相关癌症治疗的潜在靶点
Toxics. 2025 May 28;13(6):448. doi: 10.3390/toxics13060448.
2
Investigating HMGB1 as a potential serum biomarker for early diabetic nephropathy monitoring by quantitative proteomics.通过定量蛋白质组学研究高迁移率族蛋白B1作为早期糖尿病肾病监测潜在血清生物标志物的情况。
iScience. 2024 Jan 8;27(2):108834. doi: 10.1016/j.isci.2024.108834. eCollection 2024 Feb 16.
3
Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers.

本文引用的文献

1
The Role of Yes-Associated Protein (YAP) in Regulating Programmed Death-Ligand 1 (PD-L1) in Thoracic Cancer.Yes相关蛋白(YAP)在调控肺癌程序性死亡配体1(PD-L1)中的作用
Biomedicines. 2018 Dec 7;6(4):114. doi: 10.3390/biomedicines6040114.
2
Nuclear grading, BAP1, mesothelin and PD-L1 expression in malignant pleural mesothelioma: prognostic implications.恶性胸膜间皮瘤的核分级、BAP1、间皮素和 PD-L1 表达:预后意义。
Pathology. 2018 Oct;50(6):635-641. doi: 10.1016/j.pathol.2018.05.002. Epub 2018 Aug 23.
3
Current treatments and trials in malignant pleural mesothelioma.
胸膜间皮瘤:血液和胸膜生物标志物的进展
J Clin Med. 2023 Nov 9;12(22):7006. doi: 10.3390/jcm12227006.
4
Tumor-associated neutrophils upregulate PANoptosis to foster an immunosuppressive microenvironment of non-small cell lung cancer.肿瘤相关中性粒细胞上调 PANoptosis 以促进非小细胞肺癌的免疫抑制微环境。
Cancer Immunol Immunother. 2023 Dec;72(12):4293-4308. doi: 10.1007/s00262-023-03564-7. Epub 2023 Oct 31.
5
Exposure of Rats to Multi-Walled Carbon Nanotubes: Correlation of Inhalation Exposure to Lung Burden, Bronchoalveolar Lavage Fluid Findings, and Lung Morphology.大鼠暴露于多壁碳纳米管:吸入暴露与肺负荷、支气管肺泡灌洗液体征及肺形态学的相关性
Nanomaterials (Basel). 2023 Sep 20;13(18):2598. doi: 10.3390/nano13182598.
6
[Tumor cell lysate with low content of HMGB1 enhances immune response of dendritic cells against lung cancer in mice].[低含量高迁移率族蛋白B1的肿瘤细胞裂解物增强小鼠树突状细胞对肺癌的免疫反应]
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Jun 20;43(6):906-914. doi: 10.12122/j.issn.1673-4254.2023.06.05.
7
ATG5 as biomarker for early detection of malignant mesothelioma.ATG5 作为恶性间皮瘤早期检测的生物标志物。
BMC Res Notes. 2023 Apr 24;16(1):61. doi: 10.1186/s13104-023-06330-1.
8
Assessment of the toxicity and carcinogenicity of double-walled carbon nanotubes in the rat lung after intratracheal instillation: a two-year study.经气管滴注后大鼠肺部的双层碳纳米管的毒性和致癌性评估:一项为期两年的研究。
Part Fibre Toxicol. 2022 Apr 22;19(1):30. doi: 10.1186/s12989-022-00469-8.
9
Subcellular localization of HMGB1 in human cholangiocarcinoma: correlation with tumor stage.HMGB1在人胆管癌中的亚细胞定位:与肿瘤分期的相关性
Discov Oncol. 2021 Nov 8;12(1):49. doi: 10.1007/s12672-021-00446-1.
10
Use of an antagonist of HMGB1 in mice affected by malignant mesothelioma: a preliminary ultrasound and optical imaging study.在恶性间皮瘤小鼠中使用 HMGB1 拮抗剂:一项初步的超声和光学成像研究。
Eur Radiol Exp. 2022 Feb 8;6(1):7. doi: 10.1186/s41747-021-00260-y.
恶性胸膜间皮瘤的当前治疗方法与试验
Clin Respir J. 2018 Jul;12(7):2161-2169. doi: 10.1111/crj.12938.
4
Suppressed epithelial-mesenchymal transition and cancer stem cell properties mediate the anti-cancer effects of ethyl pyruvate via regulation of the AKT/nuclear factor-κB pathway in prostate cancer cells.抑制上皮-间质转化和癌症干细胞特性通过调节前列腺癌细胞中的AKT/核因子-κB途径介导丙酮酸乙酯的抗癌作用。
Oncol Lett. 2018 Aug;16(2):2271-2278. doi: 10.3892/ol.2018.8958. Epub 2018 Jun 12.
5
Scientific Advances and New Frontiers in Mesothelioma Therapeutics.《间皮瘤治疗的科学进展与新前沿》
J Thorac Oncol. 2018 Sep;13(9):1269-1283. doi: 10.1016/j.jtho.2018.06.011.
6
Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on.恶性胸膜间皮瘤早期诊断和预后的生物标志物:探索仍在继续。
Cancers (Basel). 2018 Jun 15;10(6):203. doi: 10.3390/cancers10060203.
7
A Phase II Trial of First-Line Combination Chemotherapy With Cisplatin, Pemetrexed, and Nivolumab for Unresectable Malignant Pleural Mesothelioma: A Study Protocol.无法切除恶性胸膜间皮瘤一线化疗联合顺铂、培美曲塞和纳武利尤单抗的 II 期临床试验:研究方案。
Clin Lung Cancer. 2018 Sep;19(5):e705-e707. doi: 10.1016/j.cllc.2018.05.001. Epub 2018 May 9.
8
MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma.微小 RNA 介导的人肝细胞癌中高迁移率族蛋白 B1 的调控。
Biomed Res Int. 2018 Jan 31;2018:2754941. doi: 10.1155/2018/2754941. eCollection 2018.
9
High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells.高迁移率族蛋白 B1(HMGB1)在细胞内外均作为警报素发挥作用。
Semin Immunol. 2018 Aug;38:40-48. doi: 10.1016/j.smim.2018.02.011. Epub 2018 Mar 9.
10
The Effect of Flaxseed in Breast Cancer: A Literature Review.亚麻籽对乳腺癌的影响:文献综述
Front Nutr. 2018 Feb 7;5:4. doi: 10.3389/fnut.2018.00004. eCollection 2018.